Apolipoprotein (a) as a Predictor of Cardiovascular Diseases
Apolipoprotein (a) as a Predictor of Cardiovascular Diseases among Type 2 Diabetes patients in Gaza Strip
Versandkostenfrei!
Versandfertig in 1-2 Wochen
36,99 €
inkl. MwSt.
PAYBACK Punkte
18 °P sammeln!
Type 2 diabetes mellitus have a considerably higher risk of cardiovascular morbidity and mortality. Most of this excess risk is it associated with factors such as hypertension, dyslipidaemia in these patients. However about 27% in Palestine (Ministry of Health, 2014). Assessment and management of patients at high risk of diabetes can enhance early prognoses of future CVD complications and is of a vital concern globally. Understanding the status of Lp(a) among T2DM patients could provide clear picture of the main complications of this disease and enable us to guide policy makers to put new stra...
Type 2 diabetes mellitus have a considerably higher risk of cardiovascular morbidity and mortality. Most of this excess risk is it associated with factors such as hypertension, dyslipidaemia in these patients. However about 27% in Palestine (Ministry of Health, 2014). Assessment and management of patients at high risk of diabetes can enhance early prognoses of future CVD complications and is of a vital concern globally. Understanding the status of Lp(a) among T2DM patients could provide clear picture of the main complications of this disease and enable us to guide policy makers to put new strategies to avoid these complications. No previous study investigated the role of Lp(a) and the hs.CRP among T2DM in Palestine as a high risk group of developing CVD was made.
Andere Kunden interessierten sich für
